Prague, Czechia

Alois Piskala


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alois Piskala: Innovator in Antiviral Agents

Introduction

Alois Piskala is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of antiviral agents, particularly through his innovative work on azacytosine derivatives. His research focuses on developing compounds that can inhibit viral replication, offering potential treatments for various viral infections.

Latest Patents

Alois Piskala holds a patent for "Azacytosine derivatives useful as antiviral agents." This invention provides 5-azacytosine derivatives that exhibit antiviral activity, specifically targeting DNA viruses such as pox-, papilloma-, and herpes viruses in humans. The patent also includes pharmaceutical compositions that combine these derivatives with pharmaceutically acceptable carriers, aimed at treating subjects suffering from viral infections. He has 1 patent to his name.

Career Highlights

Throughout his career, Alois Piskala has worked with esteemed institutions, including K.U. Leuven Research & Development and the Institute of Organic Chemistry and Biochemistry at the Academy of Sciences of the Czech Republic. His work has been instrumental in advancing the understanding and treatment of viral diseases.

Collaborations

Alois has collaborated with notable colleagues such as Antonin Holy and Marcela Krecmerova. Their combined expertise has contributed to the success of his research endeavors.

Conclusion

Alois Piskala's innovative work in developing antiviral agents showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of viral infections, highlighting the importance of research in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…